Home›Stock Screener›Indegene›Quarterly Results

Indegene Quarterly Results

Latest Quarter Net Profit
₹112 Cr
QSept 2026
Quarterly Results

Indegene quarterly results. In Sept 2026, Indegene (INDGN) reported revenue ₹1,137 Cr and net profit ₹112 Cr — revenue +38.0% YoY. Also explore Indegene share price performance to track price trends across different timeframes.

INDGN Quarterly Results — Revenue, Profit & EPS Highlights

Indegene latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit INDGN stock price BSE.

  • Revenue of ₹1,137 Cr in Sept 2026 (+12.1% vs Mar 2026, +38.0% vs Sept 2025)
  • Net Profit of ₹112 Cr in Sept 2026 (+40.0% vs Mar 2026, +9.8% vs Sept 2025)
  • EBITDA of ₹201 Cr in Sept 2026 (+30.5% vs Mar 2026)
  • Operating Margin of 17.0% in Sept 2026 (+3.0pp vs Mar 2026)
  • Earnings Per Share of ₹4.67 in Sept 2026 (+40.7% vs Mar 2026)

Indegene Quarterly Results — Revenue, EBITDA, Net Profit & EPS

INDGN quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 1,137 1,014 1,092 824 781 12.1% 38.0%
Net Profit (₹ Cr) 112 80 116 102 118 - -
EBITDA (₹ Cr) 201 154 203 160 173 - -
EPS (₹) 4.67 3.32 4.84 4.26 4.91 - -
Operating Margin (%) 17.0% 14.0% 16.0% 17.0% 20.0% - -

INDGN Share Price Trend — 1-Year Movement Across Quarterly Results

Indegene 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. View INDGN price range for the annual high/low range and current price position.

Profitability Ratios

Profit Margin 9.9%
EBITDA Margin 17.7%
Operating Margin 17.0%
ROE (Annual) 14.3%

Balance Sheet Highlights

Total Assets ₹4,620 Cr
Total Equity ₹3,139 Cr
Current Assets ₹ Cr
Current Liabilities ₹395 Cr

Cash Flow Analysis

Operating Cash Flow ₹651 Cr
Investing Cash Flow ₹-508 Cr
Financing Cash Flow ₹-83 Cr
Net Cash Flow ₹60 Cr

Current Market Data

Current Price ₹645.40
Exchange NSE
Last Updated Nov 19, 2026

INDGN vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Indegene latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores